Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - oseltamivir phosphate, quantity: 59.114 mg - capsule, hard - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; sodium stearylfumarate; povidone; purified talc; ethanol absolute; titanium dioxide; purified water; gelatin; iron oxide black - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - oseltamivir phosphate, quantity: 39.41 mg - capsule, hard - excipient ingredients: sodium stearylfumarate; ethanol absolute; pregelatinised maize starch; croscarmellose sodium; povidone; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - lupin flour allergen extract - solution for skin-prick test

Canada - English - Health Canada

lupin pharma canada limited - tiotropium (tiotropium bromide monohydrate) - capsule - 18mcg - tiotropium (tiotropium bromide monohydrate) 18mcg

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - escitalopram oxalate -

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - memantine hydrochloride -

Canada - English - Health Canada

lupin pharma canada limited - propranolol hydrochloride - capsule (extended release) - 60mg - propranolol hydrochloride 60mg - beta-adrenergic blocking agents

Canada - English - Health Canada

lupin pharma canada limited - propranolol hydrochloride - capsule (extended release) - 80mg - propranolol hydrochloride 80mg - beta-adrenergic blocking agents

Canada - English - Health Canada

lupin pharma canada limited - propranolol hydrochloride - capsule (extended release) - 120mg - propranolol hydrochloride 120mg - beta-adrenergic blocking agents